InvestorBrandNetwork (IBN) Content Platform

Safety Shot (NASDAQ: SHOT), the revolutionary dietary supplement dedicated to stopping the negative effects of alcohol before they start, is undergoing a rebrand, including a new name: Sure Shot. The company partnered with Amalgam for the rebrand initiative. A full-service agency known with a proven track record of growing brands, Amalgam is supporting Sure Shot’s focus on defining, refining and expressing a distinctive position in it market. According to the announcement, the rebrand is inspired by comic-book-like art that embodies the product’s powerful and transformative functionality and includes a fresh new look and a newly improved product taste; in addition, the product is now available in four-ounce bottles and on-the-go powder stick packs.

“We could not be more pleased to introduce the new and improved Sure Shot look to the world,” said Sure Shot CEO Jarret Boon in the press release. “This rebrand marks an exciting new chapter for the company as we embrace a bold identity that communicates our powerful innovation and revolutionary solution to the masses. Our rebrand isn’t just about aesthetic; it represents the evolution of the brand, which has seen exponential growth in its first year, and our commitment to where we see Sure Shot in the future.”

To view the full press release, visit https://ibn.fm/y3d3n

About Sure Shot Inc.

Sure Shot, a wellness and dietary supplement company dedicated to the promotion of responsible drinking, has developed Sure Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy and overall mood. Sure Shot is available for purchase online at sureshot.com and Amazon. The company is introducing business-to-business sales of Sure Shot to distributors, retailers, restaurants and bars throughout 2024. For more information about the company, visit www.SureShot.com.

NOTE TO INVESTORS: The latest news and updates relating to SHOT are available in the company’s newsroom at https://ibn.fm/SHOT

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Solution providers and innovators of the pharma and healthcare industry, as well as experts in clinical trials, are invited to attend the 21st Biopharma Clinical Trials Nexus at the Holiday Inn Piscataway, Somerset, in New Jersey. This is an invite-only event that will be held from October 22, 2024, to October 23, 2024.

BioPharma Nexus focuses on creating synergies between leading pharmaceutical and biotechnology entities, along with service providers. Their objective is to provide high-quality healthcare to patients all over the globe. At the BioPharma Nexus conferences, players can explore, discover, and generate…

Read More>>

To learn more, please visit https://ibn.fm/nRQpt.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Amesite (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced that its NurseMagic(TM) app is now available on the App Store and Google Play Store. As a result, users can now download free versions of the app on iPhone or Android devices. The app uses AI to provide beneficial and easy-to-use tools. It reduces the time for nurses and caregivers to create a wide variety of required reports and document patient care, helping with technical questions and patient communication.

“We are extremely pleased to offer the app in multiple modalities – a free version for consumers and enterprise pilots that enable home health care companies to address the incredible pressure to onboard, deploy and retain staff in a growing market. Our rapidly growing enterprise engagement validates the strong need for our solution in the industry,” said Madison Bush, Corporate Operations and Marketing Manager at Amesite.

To view the full press release, visit https://ibn.fm/vabuO

About Amesite Inc.

Amesite is a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, including its higher ed platform that offers professional learning. Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional needs. NurseMagic(TM), the company’s recently launched mobile app, streamlines creation of nurse notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. The Preacto(TM) (beta) is a personal safety application designed to provide real-time alerts and guidance in the event of emergency situations, including active shooter incidents. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, has announced two updated service agreements. According to the announcement, both the New York City Fire Department (“FDNY”) and the Port Authority of New York and New Jersey (“PANYNJ”) have updated their contracts with Knightscope. Specifically, the FDNY renewed its service agreement for K1 Call Boxes while the PANYNJ added a Full Service Maintenance Plan (“FSMP”), which covers K1 Call Boxes that are installed on the George Washington Bridge.

“A life-saving event on the George Washington Bridge reported earlier this year encouraged further investment into the program,” stated the company in the press release. “And [an] FSMP will provide the Port Authority with operational confidence in the system backed up by service maintenance support and software that FDNY already enjoys. By enacting these operational fail-safes, community leaders are ensuring access to multiple portals needed to alert the appropriate authorities in times of danger, personal crisis or medical emergencies.”

To view the full press release, visit https://ibn.fm/H1Pud

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety. The company’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery technology, is sharing an update covering recent advancements in the glucagon-like peptide-1 (“GLP-1”) receptor agonist market. According to the report, the space has seen “unprecedented growth” and is “growing faster than nearly all historic forecasts had predicted.”

“Despite this unprecedented growth, GLP-1/GIP drugs currently delivered by oral tablet comprise only roughly 10% of the entire market dominated by injectable delivery,” said the company in the update. “The share of the market addressed with oral tablets is likely to grow aggressively as patients are expected to migrate away from injections as more available oral forms become available. Lexaria expects that its DehydraTECH drug-delivery system could be a global leader in GLP-1/GIP drug delivery as oral delivery dominates in the years to come.”

To view the full press release, visit https://ibn.fm/nt67a

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery formulation and processing platform technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through oral delivery. Since 2016, Lexaria has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats. DehydraTECH has repeatedly demonstrated the ability to increase bioabsorption and has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier, which Lexaria believes to be of particular importance for centrally active compounds. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 46 patents granted and many patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

N2OFF’s (NASDAQ: NITO) (FSE: 80W) (formerly known as Save Foods, Inc.) subsidiary Save Foods Ltd., an innovative, dynamic company addressing food waste and loss and food safety in the agri-food tech industry, has entered into a non-binding letter of intent (“LOI”) with GENSIS PM TDC, an Ethiopian Federal Agency. Under the LOI, announced Tuesday morning, the agency seeks to utilize Save Foods’ innovative eco-friendly solutions across Ethiopia’s large-scale farming sector, potentially supporting the country’s efforts to develop sustainable agricultural practices, enhance crop yields, and ensure food safety. David Palach, N2OFF’s CEO, believes the agreement could yield dozens of millions of dollars in revenues if consummated.

“As part of the agreement, Save Foods and the Ethiopian government will collaborate on establishing a local production facility in Ethiopia. This move ensures that Save Foods’ technologies will be accessible throughout the country, thus further supporting the transition to sustainable farming practices. The aim is for the partnership to reach a nationwide rollout, eventually requiring all farmers in Ethiopia to utilize these solutions,” said Palach.

To view the full press release, visit https://ibn.fm/oZtyg

About N2OFF Inc.

N2OFF, Inc. (formerly known as Save Foods, Inc.) is a clean tech company engaged in sustainable solutions for energy and innovation for the agri-tech. Through its operational activities, it delivers integrated solutions for sustainable energy, greenhouse gas emissions reduction and safety, quality solutions for the agri-tech market. NTWO OFF Ltd., N2OFF’s majority-owned Israeli subsidiary, aims to contribute in tackling greenhouse gas emissions, offering a pioneering solution to mitigate nitrous oxide (N ₂O) emissions, a potent greenhouse gas with 310 times the global warming impact of carbon dioxide. NTWO OFF Ltd. aims to promote agricultural practices that are both environmentally friendly and economically viable. N2OFF recently entered the solar PV market and will provide funding to Solterra Renewable Energy Ltd. for the current project with a total capacity of 111 MWp, as well as potential future projects. Save Foods Ltd., N2OFF’s majority-owned Israeli subsidiary, focuses on post-harvest treatments in fruit and vegetables to control and prevent pathogen contamination. N2OFF also has a minority ownership in Plantify Foods Inc. (TSX.V: PTFY), a Canadian company listed on the TSXV that offers a wide range of clean-label healthy food options.  For more information about N2OFF and NTWO OFF, visit www.N2OFF.com.

NOTE TO INVESTORS: The latest news and updates relating to N2OFF are available in the company’s newsroom at https://ibn.fm/NITO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated biopharmaceutical company with marketed products and a pipeline of development candidates, is collaborating with X-Chem Inc., a leader in small molecule drug discovery. According to the announcement, the two companies are collaborating on an artificial intelligence (“AI”) and machine learning (“ML”) project designed to accelerate development of Tonix’s oral broad-spectrum antivirals. Tonix’s TNX-4200 antiviral program targets the development of oral CD45 phosphatase inhibitors, with broad-spectrum activity against a range of viral families.

“We are excited to enter into this research collaboration with X-Chem, which we believe will expand our capabilities and deepen our understanding of host-targeted small molecule therapeutics for a variety of targets,” said Tonix Pharmaceuticals CEO Seth Lederman, MD, in the press release. “With the support of X-Chem’s drug discovery AI/ML technology, we expect to optimize the physicochemical properties, pharmacokinetics and safety attributes of our drug candidates.”

To view the full press release, visit https://ibn.fm/TDl70

About Tonix Pharmaceuticals Holding Corp.

Tonix is a fully integrated biopharmaceutical company focused on transforming therapies for pain management and modernizing solutions for public health challenges. Tonix’s priority is to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) this month for TNX-102 SL, a product candidate for which two statistically significant phase 3 studies have been completed for the management of fibromyalgia. TNX-102 SL was generally well tolerated in the phase 3 program. The FDA has granted Fast Track designation to TNX-102 SL for the management of fibromyalgia. TNX-102 SL is also being developed to treat acute stress reaction. Tonix recently announced that the U.S. Department of Defense (“DoD”), Defense Threat Reduction Agency (“DTRA”) awarded it a contract for up to $34 million over five years to develop TNX-4200, small molecule broad-spectrum antiviral agents targeting CD45 for the prevention or treatment of infections to improve the medical readiness of military personnel in biological threat environments. Tonix owns and operates a state-of-the art infectious disease research facility in Frederick, Maryland. The company’s Good Manufacturing Practice (“GMP”)-capable advanced manufacturing facility in Dartmouth, Maryland, was purpose-built to manufacture TNX-801, and the GMP suites are ready to be reactivated in case of a national or international emergency. Tonix’s development portfolio is focused on central nervous system (“CNS”) disorders. Tonix’s CNS portfolio includes TNX-1300 (cocaine esterase), a biologic in Phase 2 development designed to treat cocaine intoxication that has Breakthrough Therapy designation. Tonix’s immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease. Tonix Medicines, the company’s commercial subsidiary, markets Zembrace(R) SymTouch(R) (sumatriptan injection) 3 mg and Tosymra(R)(sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults. For more information about the company, please visit www.TonixPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to TNXP are available in the company’s newsroom at https://ibn.fm/TNXP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor, today announced a partnership with Flowzz.com. Flowzz.com, a dynamic e-commerce platform distributing cannabis products, accessories and wellness solutions across Europe, is one of the most popular online cannabis marketplaces in Germany. This cooperation agreement will see the establishment of a dedicated Flora e-commerce store on the Flowzz Webshop, with Flora handling fulfillment and Flowzz overseeing the creation, maintenance and marketing of the Flora Flowzz page. The partnership will enable Flora to showcase its comprehensive product line on the Flowzz platform, including Vessel products, existing shop items, cannabis strains, and cannabis flowers.

“German pharmacists, doctors and consumers have relied on Flowzz and its e-commerce engine to educate and purchase cannabis products. By leveraging the Flowzz advanced e-commerce platform, we can reach a broader audience and enhance our customer engagement in Germany. This partnership highlights our dedication to growth in the digital space,” said Clifford Starke, CEO of Flora Growth. “This partnership aligns with our objective of offering high-quality cannabis products through an accessible online experience. We intend to work closely with Flowzz to deliver a new shopping experience for our customers in Germany.”

To view the full press release, visit https://ibn.fm/WZJNr

About Flora Growth Corp.

Flora is a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world. For more information on Flora, visit www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

SenesTech (NASDAQ: SNES), the leader in birth control to manage rodent pest populations, is reporting that the New York City Council has approved a bill to implement a rat contraception pilot program. According to the announcement, the bill stipulates that “rat contraceptive” means an agent for the reduction of reproductive capacity in rats; the bill also calls for the use of an agent approved by the U.S. Environment Protection Agency (“EPA”). Currently, SenesTech is the only manufacturer of products that meet this requirement. The bill calls for city departments to begin the program, which will run for at least 12 months in two rat-mitigation zones and a comparable area, within 180 days of enactment.

“SenesTech has two product lines on the market today, ContraPest(R) and Evolve(R), that have shown efficacy and safety in deployments throughout the United States and around the globe,” said SenesTech president and CEO Joel Fruendt in the press release. “We are the provider of Rat Birth Control(TM). We look forward to supporting New York City in their pilot program.”

To view the full press release, visit https://ibn.fm/lFC8K

About SenesTech Inc.

SenesTech is committed to improving the health of the world by humanely managing animal-pest populations through its expertise in fertility control. Senestech is the inventor of Evolve(TM) Rat and Evolve(TM) Mouse, EPA-designated, minimum-risk contraceptives for rodents, which reflects the company’s mission to provide products that are proactive, safe and sustainable. Evolve fits seamlessly into all integrated pest-management programs, significantly improving the overall goal of effective pest management. The company’s strives for clean cities, efficient businesses and happy households — with a product designed to be humane, effective and sustainable. For more information about the company, please visit www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1), the digital face of the plant-based community operating a one-stop shop for plant-based products, today announced that BloomBox Club, its online indoor plant subscription company, has been acquired by Bloomique, a Netherlands-based greenhouse provider. The acquisition expands the product catalog on BloomBox Club’s online platform by providing access to a larger range of greenhouses. According to the announcement, BloomBox Club will add 200 new SKUs to its online platform and offer customers a broader selection of plants, strengthening its presence in the indoor plant space. Following the acquisition, BloomBox Club will benefit from Flora, its fulfillment partner, as Flora will implement automated packing processes to streamline operations and enhance the overall customer experience.

“Working with Bloomique has been a breath of fresh air for us. We’ve already seen tremendous progress, and we’re excited to introduce hundreds of new SKUs to our offerings, just in time for the holiday season. We expect this expansion to drive even stronger performance during this important period,” commented Lorne Rapkin, CEO of PlantX.

To view the full press release, visit https://ibn.fm/C3veE

About PlantX Life Inc.

PlantX Life focuses on fostering niche online wellness communities as well as creating physical immersive environments. Bloombox Club, an online plant delivery marketplace operating across the U.K. and E.U., and The Locavore Bar and Grill, a unique dining experience that started as a humble food truck and coffee shop in the heart of Squamish, B.C., are key verticals of PlantX. The company recently completed a share exchange agreement and is now an owner in VEG House, a company whose portfolio of assets is leading the way in the plant-based space. PlantX works to build a community of like-minded consumers and provide education on plant-based living. Its enterprise is built on partnerships and collaboration. The company’s digital presence aims to eliminate barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information about the company, please visit www.PlantX.com and www.PlantX.ca.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Aditxt (NASDAQ: ADTX), an innovation platform dedicated to accelerating promising health innovations, and its acquisition target Evofem Biosciences (OTCQB: EVFM), a women’s health company, have completed the Third Parent Equity Investment under its Amended and Restated Merger Agreement. According to the announcement, this strengthens the strategic and collaborative relationship between the two companies, which share a commitment to expand access to healthcare solutions for women around the world.

The announcement noted that Aditxt completed the investment by purchasing 460 shares of Evofem Series F-1 Convertible Preferred Stock for $460,000; this is in addition to the company’s previous investments in Evofem, which total $1.72 million. Aditxt also plans to complete the Fourth Parent Equity Investment by purchasing an additional 2,280 shares of Evofem Preferred Stock for $2.28 million; this purchase is anticipated by Oct. 31, 2024.

To view the full press release, visit https://ibn.fm/FsnRP

About Aditxt Inc.

Aditxt is an innovation platform dedicated to accelerating promising health innovations. Aditxt’s ecosystem of research institutions, industry partners and shareholders collaboratively drives its mission to “Make Promising Innovations Possible Together.” The innovation platform is the cornerstone of Aditxt’s strategy, where multiple disciplines drive disruptive growth and address significant societal challenges. Aditxt operates a unique model that democratizes innovation, ensures every stakeholder’s voice is heard and valued, and empowers collective progress. Aditxt currently operates two programs focused on immune health and precision health. The company plans to introduce two additional programs dedicated to public health and women’s health. For these, Aditxt has entered into an arrangement agreement with Appili Therapeutics Inc. (TSX: APLI) (OTC: APLIF), which focuses on infectious diseases, and a merger agreement with Evofem. Each program will be designed to function autonomously while collectively advancing Aditxt’s mission of discovering, developing and deploying innovative health solutions to tackle some of the most urgent health challenges. The closing of the transactions with Appili and Evofem is subject to several conditions, including but not limited to approval of the transactions by the respective target shareholders and Aditxt raising sufficient capital to fund its obligations at closing. No assurance can be given that all of the conditions to closing will be obtained or satisfied or that either of the transactions will ultimately close. For more information, please visit www.Aditxt.com.

NOTE TO INVESTORS: The latest news and updates relating to ADTX are available in the company’s newsroom at https://ibn.fm/ADTX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Aditxt (NASDAQ: ADTX), an innovation platform dedicated to accelerating promising health innovations, and its acquisition target Evofem Biosciences (OTCQB: EVFM), a women’s health company, have completed the Third Parent Equity Investment under its Amended and Restated Merger Agreement. According to the announcement, this strengthens the strategic and collaborative relationship between the two companies, which share a commitment to expand access to healthcare solutions for women around the world.

The announcement noted that Aditxt completed the investment by purchasing 460 shares of Evofem Series F-1 Convertible Preferred Stock for $460,000; this is in addition to the company’s previous investments in Evofem, which total $1.72 million. Aditxt also plans to complete the Fourth Parent Equity Investment by purchasing an additional 2,280 shares of Evofem Preferred Stock for $2.28 million; this purchase is anticipated by Oct. 31, 2024.

To view the full press release, visit https://ibn.fm/FsnRP

About Aditxt Inc.

Aditxt is an innovation platform dedicated to accelerating promising health innovations. Aditxt’s ecosystem of research institutions, industry partners and shareholders collaboratively drives its mission to “Make Promising Innovations Possible Together.” The innovation platform is the cornerstone of Aditxt’s strategy, where multiple disciplines drive disruptive growth and address significant societal challenges. Aditxt operates a unique model that democratizes innovation, ensures every stakeholder’s voice is heard and valued, and empowers collective progress. Aditxt currently operates two programs focused on immune health and precision health. The company plans to introduce two additional programs dedicated to public health and women’s health. For these, Aditxt has entered into an arrangement agreement with Appili Therapeutics Inc. (TSX: APLI) (OTC: APLIF), which focuses on infectious diseases, and a merger agreement with Evofem. Each program will be designed to function autonomously while collectively advancing Aditxt’s mission of discovering, developing and deploying innovative health solutions to tackle some of the most urgent health challenges. The closing of the transactions with Appili and Evofem is subject to several conditions, including but not limited to approval of the transactions by the respective target shareholders and Aditxt raising sufficient capital to fund its obligations at closing. No assurance can be given that all of the conditions to closing will be obtained or satisfied or that either of the transactions will ultimately close. For more information, please visit www.Aditxt.com.

NOTE TO INVESTORS: The latest news and updates relating to ADTX are available in the company’s newsroom at https://ibn.fm/ADTX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

• DiPasquale was featured in publications discussing his journey from the tech industry to entrepreneurship with Epic Golf Club and now GolfLync.
• Since its inception in 2018, Epic Golf Club, partnering with 200 private clubs in 43 states, plus first-rate clubs in 13 countries, has become known for its exclusive membership and five-star experiences, now having grown to 1,000 members.
• DiPasquale has brought that same sense of golfing dedication to GolfLync, an unmatched social networking platform, uniting golf enthusiasts in a top-tier golfing community of players and clubs.

GolfLync CEO and Co-Founder Noah DiPasquale, a visionary known for reimagining industries, is dedicated to providing an epic experience to all members of his exclusive Epic Golf Club, and now fostering a dynamic golfing community with GolfLync, a pioneering golf social networking platform where golf enthusiasts can come together and enjoy the game at its highest level.

In a series of recent articles highlighting DiPasquale’s journey from the tech industry to entrepreneurship and the unique experience offered by Epic Golf Club, the entrepreneur discusses what sets his projects apart in the golfing community, what inspired him to create Epic Golf Club, as well as the…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

BlockQuarry (OTC: BLQC), a leading Texas-based sustainable energy and high-performance computing (“HPC”) infrastructure company, today announced that it has acquired two established home healthcare companies, Telecare Home Health LLC and Paradigm Home Health LLC. According to the announcement, the acquisitions expand BlockQuarry’s patient base, access to valuable data, and capabilities to deliver artificial intelligence (“AI”)-driven innovation and enhance patient outcomes through clinical trials and real-world data analytics. The acquisitions are expected to drive operational growth and improve BlockQuarry’s service offerings, positioning the company for continued expansion within the healthcare industry.

“These acquisitions are key steps in our long-term vision to strengthen BlockQuarry’s position as an innovator in healthcare solutions. By combining our expertise in AI with the capabilities of Telecare and Paradigm, we’re accelerating clinical trial development and reshaping patient care,” said Alonzo Pierce, Chairman and President of BlockQuarry.

To view the full press release, visit https://ibn.fm/F8Gw1

About BlockQuarry Corp.

BlockQuarry Corp. is at the forefront of innovation in the U.S. energy and infrastructure sectors, with a dedicated focus on advancing the deployment of carbon-negative industrial energy on a global scale. The company specializes in providing green, sustainable, and economically viable energy alternatives to industries with significant power needs, including data storage hubs, manufacturing, cryptocurrency mining and AI. Visit www.blockquarry.io to learn more about the company.

NOTE TO INVESTORS: The latest news and updates relating to BLQC are available in the company’s newsroom at http://ibn.fm/BLQC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Oragenics Inc. (NYSE American: OGEN) has successfully completed a key FDA-recognized study for its concussion treatment drug, ONP-002. Delivered via a nasal spray, ONP-002 demonstrated the ability to target areas within the nose directly linked to the brain, increasing the likelihood of reaching the brain quickly after an injury. The study, utilizing an FDA-approved intranasal casting model, paves the way for Phase II trials where ONP-002 will be administered to concussion patients within eight hours of injury. Oragenics’ breakthrough aims to fill the unmet need for pharmaceutical treatment in concussion care.

“In preparing for our Phase II study, we wanted to study whether our nasal spray device would give ONP-002 an increased chance of reaching the brain quickly after a concussion,” Michael Redmond, President of Oragenics, stated in the news release. “The study results are promising, as they show the drug targets areas in the nose directly linked to the brain. This should increase the chances of the drug being effective in treating concussion and reduces the likelihood of it being swallowed, which is another encouraging sign.”

To view the full press release, visit https://ibn.fm/5bNwp

About Oragenics

Oragenics is a development-stage biotechnology company focused on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI), also known as concussion, and for treating Niemann Pick Disease Type C (NPC), as well as proprietary powder formulation and an intranasal delivery device. For more information, visit the company’s website at www.Oragenics.com

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, including obstructive sleep apnea (“OSA”) in adults and children, reported that the American Medical Association (“AMA”) has issued new CPT(R)medical codes that are applicable to Vivos CARE oral medical devices; the codes are effective beginning Jan. 1, 2025.

“This is exciting news for OSA patients and medical providers who treat sleep breathing disorders,” said Vivos Therapeutics CEO and chair Kirk Huntsman in the press release. “Our CARE oral medical devices are the only ones cleared by the U.S. Food and Drug Administration for the treatment of moderate to severe OSA, and these new medical codes will now facilitate coverage and reimbursement by commercial medical insurance payers. From Vivos’ perspective, we believe this will enable a larger number of patients from most demographics to access our breakthrough, proprietary airway remodeling technology and more effectively treat their OSA.”

To view the full press release, visit https://ibn.fm/izCV5

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (“OSA”) and snoring in adults and children. The Vivos Method represents the first clinically effective nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to severe OSA in adults and moderate to severe OSA in children. It has proven effective in more than 45,000 patients treated worldwide by more than 2,000 trained dentists. The Vivos Method includes treatment regimens that employ the proprietary CARE appliance therapy and other modalities that alter the size, shape and position of the jaw and soft tissues that comprise a patient’s upper airway and/or palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild-to-severe OSA in adults and moderate-to-severe OSA in children aged 6 to 17, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using the Vivos Method. Vivos also employs a marketing and distribution model where it collaborates with sleep-treatment providers to offer patients OSA treatment options and help promote sales of its appliances. For more information about this company, visit www.VivosLife.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

SUIC Worldwide Holdings (OTC: SUIC), a publicly traded technology company, and SUIC Beneway have appointed a new director. According to the announcement, Paul G.W. Fetscher, CCIM, CRX, CLS, joins Beneway as a director in preparation for the company to file with the U.S. Securities and Exchange Commission prior to an IPO. President of New York-based Great American Brokerage Inc., Fetscher has also served as past president of New York State Commercial Association of Realtor and chair of two airport retail conventions. Throughout his career, he has gained impressive expertise in retail concept as well as design and development for restaurants, lifestyle centers, downtown redevelopment, urban renewal, regional malls, specialty and entertainment centers, factory outlet centers and airports.

“SUIC is the biggest investor and shareholder and a major U.S. operating partner of Beneway,” said SUIC Worldwide Holdings CEO Hank Wang in the press release. “Our group is inviting more talents and experts to join us to accelerate business expansion and IPO. This transaction will facilitate more resources for us to boost our investment and operational capacity and reinforce our shareholder structure. Looking ahead, we remain committed to driving innovation with a clear growth forecast, leveraging our strategic investments and partnerships to create more lucrative value for our shareholders and customers. We are grateful for the continued support of our shareholders, customers, vendors and partners, and look forward to a successful year ahead.”

To view the full press release, visit https://ibn.fm/kTYPr

About SUIC Worldwide Holdings Ltd.

SUIC Worldwide Holdings provides research and development along with venture financing for and investing in private enterprises and the public sector that develop products and services adopting core capabilities of the Internet of Things (“IoT”), cloud computing, mobile payment, big data, blockchain and artificial intelligence (“AI”), to enhance and streamline existing processes, and establish new and exciting business models that will create revolutionary products and services. Shareholders of SUIC will be exposed to the diverse application of advanced services in various parts of the economy. Additionally, existing and potential customers can benefit from the company’s diversified portfolio of technologies. As one of the pioneering publicly traded technology companies, SUIC will help build tech-enabled businesses of the future. For more information, please visit www.SINOUnitedco.com.

NOTE TO INVESTORS: The latest news and updates relating to SUIC are available in the company’s newsroom at https://ibn.fm/SUIC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

NanoViricides (NYSE American: NNVC) is a development-stage company that is creating special purpose nanomaterials for antiviral therapy. NanoViricides’ President and Executive Chairman Anil R. Diwan, Ph.D., is expected to present at the Global AMR Summit, the premier forum for anti-microbial resistance (“AMR”), to be held at the Kimpton Marlowe Hotel in Cambridge, MA, on October 9, 2024. Dr. Diwan will discuss the company’s “shape-shifting,” “Trojan Horse” platform technology, which facilitates the delivery of one or more “war-heads” against a pathogen to combat AMR. The technology delivers these “war-heads” directly onto the pathogen without affecting normal host cells, thus reducing toxicity and improving pharmacokinetics.

“The ‘shape-shifting’ nanoviricide(TM) platform technology opens up new avenues for combatting anti-microbial resistance,” said Dr. Diwan. “We have already developed nanoviricide drugs against viruses that promise to combat the problem of viral escape from a drug. We believe this technology can be applied to develop novel anti-microbial drugs in order to solve the AMR problem.”

To view the full press release, visit https://ibn.fm/zZrrE

About NanoViricides Inc.

NanoViricides is a development-stage company that is creating special purpose nanomaterials for antiviral therapy. The company’s novel nanoviricide(TM) class of drug candidates and the nanoviricide(TM) technology are based on intellectual property, technology and proprietary know-how of TheraCour Pharma, Inc. The company has a Memorandum of Understanding with TheraCour for the development of drugs based on these technologies for all antiviral infections. The MoU does not include cancer and similar diseases that may have viral origin but require different kinds of treatments. The company has obtained broad, exclusive, sub-licensable, field licenses to drugs developed in several licensed fields from TheraCour Pharma, Inc. The company’s business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, as established at its foundation in 2005. NanoViricides’ lead drug candidate is NV-387, a broad-spectrum antiviral drug that the company plans to develop as a treatment of RSV, COVID-19, Long COVID, influenza, and other respiratory viral infections, as well as MPOX/Smallpox infections. The company is currently focused on advancing NV-387 into Phase II human clinical trials. NanoViricides’ other advanced candidate is NV-HHV-1 for the treatment of Shingles. The company cannot project an exact date for filing an IND for any of its drugs because of dependence on a number of external collaborators and consultants. NV-CoV-2 (“API NV-387”) is the company’s nanoviricide drug candidate for COVID-19 that does not encapsulate remdesivir. NV-CoV-2-R is NanoViricides’ other drug candidate for COVID-19 that is made up of NV-387 with remdesivir encapsulated within its polymeric micelles. For more information about the company, visit www.NanoViricides.com.

NOTE TO INVESTORS: The latest news and updates relating to NNVC are available in the company’s newsroom at https://ibn.fm/NNVC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

The 3rd Annual Roth Healthcare Opportunities Conference will be held at the Metropolitan Club in New York, NY on October 9, 2024. Healthcare professionals, executives, businesses, industries, and investors of the allied healthcare sectors are invited for a full day of networking, learning and collaboration with peers and industry leaders.

This event focuses on an extensive format where executives and professionals from the Biotechnology, Brain Disorders, Medical Technologies, Oncology Therapeutics, and Pharmaceuticals sectors, gain deep…

Read More>>

To learn more, please visit https://ibn.fm/1LfAT

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Orthofix Medical (NASDAQ: OFIX) is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, the company delivers exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH(TM) Navigation System.

For more information, visit the company’s website at: www.Orthofix.com or contact Investor Relations at [email protected].

To view IBN’s virtual coverage of the 3rd Annual Healthcare Opportunities Conference, visit https://events.investorbrandnetwork.com/2024/roth-healthcare/

About InvestorBrandNetwork’s Virtual Coverage

IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at ROTH’s 3rd Annual Healthcare Opportunities Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

EverGen (TSX.V: EVGN) (OTCQX: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has appointed a new auditor. The company announced that it has changed auditors, switching from PricewaterhouseCoopers LLP to Davidson & Company LLP. The change is effective Oct. 1, 2024, and will remain effective until the company’s next Annual General Meeting. The change was approved by the company’s board of directors and audit committee. “There were no reservations, modified opinions or reportable events (as defined in National Instrument 51-102) in the former auditor’s reports on the company’s financial statements for the ‎period commencing at the beginning of the company’s two most recently completed financial years and ‎ending on the date of termination of the former auditor,” stated the company in the press release.

To view the full press release, visit https://ibn.fm/dsceV

About EverGen Infrastructure Corp.

EverGen, Canada’s renewable natural gas infrastructure platform, is combating climate change and helping communities contribute to a sustainable future. Headquartered on the west coast of Canada, EverGen is an established independent renewable energy producer that acquires, develops, builds, owns and operates a portfolio of renewable natural gas, waste-to-energy and related infrastructure projects. EverGen is focused on Canada, with continued growth expected across other regions in North America and beyond. For more information about EverGen and its products, visit www.EverGenInfra.com.

NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Foremost Clean Energy (NASDAQ: FMST) (CSE: FAT), an emerging North American uranium and lithium exploration company, announced Monday morning that it has officially closed the first phase of its transaction with Denison Mines Corp. (TSX: DML) (NYSE American: DNN). The company has acquired 20% of Denison’s interest in 10 uranium exploration properties in the Athabasca Basin in Northern Saskatchewan, covering more than 330,000 acres. In addition to other considerations, Denison was issued an aggregate of 1,369,810 common shares of Foremost, becoming the Foremost’s largest shareholder at 19.95%. Denison today announced the filing of an early warning report, under National Instrument 62-103, regarding this holding in Foremost.

Foremost has also appointed David Cates, President and CEO of Denison, to its board of directors and Andy Yackulic, Denison’s VP of Exploration, as a technical and geoscientific advisor in its advisory board. In addition, the company has entered into an investor rights agreement with Denison and become the operator of the ten properties.

“We are pleased to officially close the first phase of this transformational transaction, marking a significant milestone for Foremost and its shareholders. The company is fortunate to acquire an interest in a large portfolio of ten prospective projects situated amongst well-established infrastructure, mills and operating mines,” said Jason Barnard, President and CEO of Foremost.

To view the full press releases, visit https://ibn.fm/oY16X and https://ibn.fm/V6fn8

About Foremost Clean Energy Ltd.

Foremost Clean Energy, assuming the effectiveness of the transaction, will be an emerging North American uranium exploration company with interests in 10 prospective properties spanning over 330,000 acres in the prolific, uranium-rich Athabasca Basin. As global demand for decarbonization accelerates, the need for nuclear power is crucial. Foremost expects to be positioned to capitalize on the growing demand for uranium through discovery in a top jurisdiction with the objective to support the world’s energy-transition goals. Alongside its exploration partner Denison, Foremost will be committed to a strategic and disciplined exploration strategy to identify resources by testing drill–ready targets with identified mineralization along strike of recent major discoveries. Foremost also maintains a secondary portfolio of significant lithium projects at different stages of development spanning over 50,000 acres across Manitoba and Quebec. For more information about the company, visit www.ForemostCleanEnergy.com.  

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Leaders, professionals and executives from the Quantitative Investment spectrum are invited to attend the Quant Strats Conference, being held October 8, 2024, at the Convene 22 Bishopsgate, London. The focus of the event will be the exploration of new avenues to generate Alpha, and how the rapidly changing global economy impacts the investment landscape.

Experts in Quantitative Investments will gather at the Quant Starts Conference to discuss topics of most relevance, including meta-data, and the application of AI, ML, NLP, and LLMs in financial markets, as well as exploring key alternative assets for alpha generation, and how to build high-performing…

Read More>>

To know more, please visit https://ibn.fm/6a55t

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

MoneyShow, a premier financial education platform that connects investors, traders and financial experts through conferences, webinars and insightful content, is spotlighted in the latest episode of the Stock2Me Podcast, presented by IBN. During the episode, MoneyShow editor-in-chief Mike Larson talks with podcast host Jonathan Keim about MoneyShow, mentioning that the platform has been around for more than four decades and has established a remarkable history of running live and online events across the United States. Larson noted that the next event — MoneyShow Traders Expo Orlando — is scheduled for Oct. 17–19, 2024, in Orlando.

“We’re going to have everything from keynotes and panels to the exhibit hall, where you can go test products and services and watch live trading demonstrations,” said MoneyShow editor-in-chief Mike Larson during the podcast. “It comes about three weeks before the presidential election. Regardless of who wins, attendees will learn how to adjust their portfolios to either maximize profits under the new administration or protect themselves from some of the issues that might come up. In our opinion, it’s a very well-timed event.”

To view the agenda and register for the event, visit https://ibn.fm/Q6ZVX

To listen to the full Stock2Me episode, visit https://ibn.fm/7VZf9

To view the full press release, visit https://ibn.fm/urU4f

About the MoneyShow

MoneyShow’s mission is to help individuals “Invest Smarter, Trade Wiser.” Each year, the privately held financial media company hosts a series of in-person conferences and virtual expos that attract more than 75,000 investors, traders and financial advisors. They gather with top market experts from a wide range of disciplines in the United States and Canada, as well as online, seeking financial education and empowerment. MoneyShow is headquartered in Sarasota, Florida. For more information, please visit www.MoneyShow.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Trump Media & Technology Group (NASDAQ: DJT), known for its association with former President Donald Trump, is navigating significant changes. The company’s Chief Operating Officer, Andrew Northwall, resigned in late September. This comes as Donald Trump transfers more shares to a SPAC investor, amidst an ongoing court battle. These developments could impact the company’s strategic direction and investor confidence.

The stock is currently trading at $16.35, marking a 1.13% increase or $0.18. This price movement reflects investor reactions to recent company news. During the trading day, DJT’s price has varied between $15.74 and $16.49, indicating some volatility in the market.

Over the past year, DJT has experienced significant price fluctuations, with a high of $79.38 and a low of $11.75. This wide range suggests that the stock has been subject to considerable market speculation and investor sentiment shifts. The company’s market capitalization is approximately $3.27 billion, reflecting its overall value in the stock market.

DJT’s trading volume is 4.3 million shares, indicating active investor interest. This level of trading activity can be influenced by recent developments, such as leadership changes and legal battles. Investors may be closely monitoring these factors to assess their potential impact on the company’s future performance.

To view the company’s most recent earnings release, visit https://ibn.fm/gHqk0

About Trump Media & Technology Group Corp.

The mission of Trump Media & Technology Group is to end Big Tech’s assault on free speech by opening up the internet and giving people their voices back. Trump Media & Technology Group operates Truth Social, a social media platform established as a safe harbor for free expression amid increasingly harsh censorship by Big Tech corporations. For more information, visit the company’s website at www.TMTGCorp.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

LQWD Technologies (TSX.V: LQWD) (OTCQB: LQWDF), a leading provider of enterprise-grade transaction infrastructure for the Bitcoin Lightning Network, is reporting the achievement of a “significant milestone.” According to the announcement, the company has seen a substantial increase in transaction volume and, last month, the company’s routing volume reached a new monthly high of 96,946 transactions and an average of 3,231 transactions per day. In addition, the company’s LQWD-Canada node reached the No. 1 spot on the Lightning Terminal ranking, an accomplishment that represents the company’s focus on network optimization and efficient channel management.

“The increase in activity is also supported by the deployment of automated rebalancing tools, which have optimized liquidity management across LQWD’s global network,” said the company in the press release. “With over 1,200 connected channels, the company is seeing strong traction in regions, such as France, Brazil, Sweden, Italy, Singapore and Japan. LQWD is poised for continued growth as the company expands its network and enhances its infrastructure.”

To view the full press release, visit https://ibn.fm/abb86

About LQWD Technologies Corp.

LQWD is a Bitcoin-backed, audited, publicly traded company focused on building the infrastructure to enable instant, low-cost, internet-powered payments. The company is committed to delivering enterprise-ready solutions for open payments at scale using the Lightning Network. For more information, please visit www.LQwDFintech.com.

NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

ECGI (OTC: ECGI), a diversified holding company with a portfolio encompassing viticulture and luxury fashion, reported the success of Pacific Saddlery’s Allon equestrian apparel collection at the American Equestrian Trade Association (“AETA”) International trade show. “Capturing the imagination of the attendees, the new line epitomized craftsmanship, innovative design and style; it best illustrated Pacific Saddlery’s commitment to combining luxury and quality with functionality. The launch included a range of show coats, show shirts, breeches, safety vest covers, and jewelry, with the safety vest cover, in particular, earning much praise from both retailers and industry experts. ECGI believes the attendees’ overwhelming response to the new Allon apparel collection attests to its potential to redefine standards in equestrian fashion,” a recent article reads. “Retailers are eager to bring our products to their customers and we are confident that the Allon line will set a new benchmark in the market,” Nick Collins, CEO of Pacific Saddlery, was quoted as saying.

To view the full article, visit https://ibn.fm/vFicb

About ECGI Holdings Inc.

ECGI is a diversified holding company with a distinctive portfolio encompassing viticulture and luxury fashion. The company owns and manages a five-acre vineyard in Lake County, California, specializing in cultivating Petite Sirah, known for its bold and rich character, which aligns with the growing demand for unique and high-quality wine experiences. In the fashion sector, ECGI has strategically invested in Pacific Saddlery, a premier manufacturer and retailer of luxury equestrian tack, apparel and accessories. This unique blend of wine and fashion investments reflects ECGI Holdings’ commitment to delivering sophistication and innovation across diverse markets, positioning the company as a distinctive player in the intersection of technology, viticulture and luxury lifestyle. For additional information, please contact the company at [email protected].

NOTE TO INVESTORS: The latest news and updates relating to ECGI are available in the company’s newsroom at https://ibn.fm/ECGI

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Investors looking for an opportunity may want to consider the rapidly evolving world of social commerce and app-based networking. In fact, taking a closer look at two players in the space — Flip and GolfLync — can show the real potential social media offers.

“Are social media networks still worthy investments? While there are naysayers who believe that the investment hype in networks like Facebook, Snapchat, and Pinterest is all but over, that is hardly the case,” reports Investopedia (https://ibn.fm/CES22). “The days of being able to invest in…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN